Led by Farapulse founder Steven Mickelsen, Field has developed a pulsed field ablation device to tackle the dangerous heart ...

Field Medical Inc., a pioneer in cardiac pulsed field ablation (PFA) technology, today announced the successful closing of ...

Such techniques can be automatically applied using implantable cardioverter defibrillators (ICDs) and offer the potential for painless termination of ventricular tachycardia (VT). Reduction in ...

Field Medical Inc., a leader in cardiac pulsed field ablation (PFA) technology, announced today its FieldForce™ Ablation ...

Adagio Medical (Nasdaq:ADGM) announced today that it received FDA breakthrough device designation for its vCLAS cryoablation ...

VT can degenerate to ventricular fibrillation ... Ablation sites (maroon circular tags) abolished ventricular tachycardia in this patient.

Field Medical secures major funding to reimagine life-saving cardiac care through next-gen ablation therapies.

Field Medical announced that it closed a Series A financing round worth $40 million to support its pulsed field ablation (PFA) technology.

SOUTH JORDAN, Utah, April 09, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader in healthcare technology, today announced the US commercial release of its Ventrax ...

Adagio Medical shares are trading higher by 142% during Thursday's session. The FDA granted Breakthrough Device Designation for the vCLAS cryoablation system.

The Growing Prevalence of VT and AF Ventricular tachycardia (VT) and atrial fibrillation (AF) are two of the most common and serious arrhythmias, contributing to stroke, heart failure, sudden ...